NCT03735147View on ClinicalTrials.gov

Assessment of Viral Shedding Week Following Administration of Live Attenuated Influenza Vaccine in Children

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 23, 2018

Primary Completion Date

April 1, 2019

Study Completion Date

April 1, 2019

Conditions

Influenza Vaccines

Interventions

BIOLOGICAL

Live attenuated influenza vaccine (LAIV)

Single dose of LAIV

Trial Locations (1)

Unknown

Imperial College Healthcare NHS Trust (St. Mary's Hospital), London

All Listed Sponsors

collaborator

Public Health England

OTHER_GOV

lead

Imperial College London

OTHER

NCT03735147 - Assessment of Viral Shedding Week Following Administration of Live Attenuated Influenza Vaccine in Children | Biotech Hunter | Biotech Hunter